Skip to content

To explore the expression of DPP4 in patients with neuropathic pain

To explore the expression of DPP4 in patients with neuropathic pain

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023655
Enrollment
Unknown
Registered
2019-06-05
Start date
2019-06-05
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic pain

Interventions

Sponsors

Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) patients who meet the diagnostic criteria for neuropathic pain. (2) aged 18 to 75 years, not receiving opioid treatment before admission. (3) voluntarily participate in the study and have signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) people who are known to have drug allergies. (2) unable to cooperate, such as combined with neurological disorders, mental disorders, etc., or unwilling to cooperate. (3) having a history of alcohol or drug abuse. (4) participants who have participated in other clinical trials within 12 weeks prior to or before the trial. (5) complicated with serious internal and surgical diseases. (6) history of severe mental illness or long-term use of psychoactive substances.

Design outcomes

Primary

MeasureTime frame
DPP4;ß-EP;IFN-?;IL-1ß;IL-17;

Countries

China

Contacts

Public ContactJiang Bian

Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University

1105593984@qq.com+86 18096308622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026